Terms: = Liver cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Treatment
94 results:
1. Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study.
Piscaglia F; Ikeda K; Cheng AL; Kudo M; Ikeda M; Breder V; Ryoo BY; Mody K; Ren M; Ramji Z; Sung MW
Cancer; 2024 Apr; 130(8):1281-1291. PubMed ID: 38261521
[TBL] [Abstract] [Full Text] [Related]
2. Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.
Camera S; Rimini M; Rossari F; Tada T; Suda G; Shimose S; Kudo M; Yoo C; Cheon J; Finkelmeier F; Lim HY; Presa J; Masi G; Bergamo F; Salani F; Marseglia M; Amadeo E; Vitiello F; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Chon HJ; Himmelsbach V; Iavarone M; Cabibbo G; Montes M; Foschi FG; Vivaldi C; Lonardi S; Sho T; Niizeki T; Nishida N; Steup C; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Hiraoka A; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Persano M; Foti S; Piscaglia F; Scartozzi M; Cascinu S; Casadei-Gardini A
Target Oncol; 2024 Jan; 19(1):29-39. PubMed ID: 38252195
[TBL] [Abstract] [Full Text] [Related]
3. Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery.
Raverdy V; Tavaglione F; Chatelain E; Caiazzo R; Saponaro C; Lassailly G; Verkindt H; Baud G; Marciniak C; Chetboun M; Oukhouya-Daoud N; Gnemmi V; Leteurtre E; Duhamel A; Philippe M; Marot G; Romeo S; Pattou F
Metabolism; 2024 Apr; 153():155790. PubMed ID: 38219973
[TBL] [Abstract] [Full Text] [Related]
4. Multidimensional Analysis of PANoptosis-Related Molecule casp8: Prognostic Significance, Immune Microenvironment Effect, and Therapeutic Implications in Hepatocellular Carcinoma.
Peng F; Zhu F; Cao B; Peng L
Genet Res (Camb); 2023; 2023():2406193. PubMed ID: 38186679
[TBL] [Abstract] [Full Text] [Related]
5. Significance of chemotherapy for older patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A propensity score matching analysis.
Chen J; Ding J; Xu Y; Hong H; Lin X; Xu M; Yan L; Xu T; Fei Z; Chen C
J Geriatr Oncol; 2023 Nov; 14(8):101648. PubMed ID: 37897887
[TBL] [Abstract] [Full Text] [Related]
6. Doxorubicin-loaded Niosomes functionalized with gelatine and alginate as pH-responsive drug delivery system: A 3D printing approach.
Zaer M; Moeinzadeh A; Abolhassani H; Rostami N; Tavakkoli Yaraki M; Seyedi SA; Nabipoorashrafi SA; Bashiri Z; Moeinabadi-Bidgoli K; Moradbeygi F; Farmani AR; Hossein-Khannazer N
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126808. PubMed ID: 37689301
[TBL] [Abstract] [Full Text] [Related]
7. Survival Benefit Relative to treatment Modalities Among Patients with Very Early Intrahepatic Cholangiocarcinoma: an Analysis of the National cancer Database.
Endo Y; Sasaki K; Munir MM; Woldesenbet S; Resende V; Rawicz-Pruszyński K; Waqar U; Mavani P; Katayama E; Yang J; Khalil M; Khan MMM; Kitago M; Pawlik TM
J Gastrointest Surg; 2023 Oct; 27(10):2103-2113. PubMed ID: 37674099
[TBL] [Abstract] [Full Text] [Related]
8. Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal cancer for liver Transplant: A Nonrandomized Controlled Trial.
Dueland S; Smedman TM; Syversveen T; Grut H; Hagness M; Line PD
JAMA Surg; 2023 Sep; 158(9):e232932. PubMed ID: 37494056
[TBL] [Abstract] [Full Text] [Related]
9. MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal liver Metastases.
Xu Y; Ye F; Li L; Yang Y; Ouyang J; Zhou Y; Wang S; Xie L; Zhou J; Zhao H; Zhao X
Acad Radiol; 2023 Sep; 30(9):2010-2020. PubMed ID: 37414635
[TBL] [Abstract] [Full Text] [Related]
10. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal cancer Group.
Bond MJG; Bolhuis K; Loosveld OJL; de Groot JWB; Droogendijk H; Helgason HH; Hendriks MP; Klaase JM; Kazemier G; Liem MSL; Rijken AM; Verhoef C; de Wilt JHW; de Jong KP; Gerhards MF; van Amerongen MJ; Engelbrecht MRW; van Lienden KP; Molenaar IQ; de Valk B; Haberkorn BCM; Kerver ED; Erdkamp F; van Alphen RJ; Mathijssen-van Stein D; Komurcu A; Lopez-Yurda M; Swijnenburg RJ; Punt CJA;
Lancet Oncol; 2023 Jul; 24(7):757-771. PubMed ID: 37329889
[TBL] [Abstract] [Full Text] [Related]
11. Global uses of traditional herbs for hepatic diseases and other pharmacological actions: A comprehensive review.
Choudhary A; Noman M; Bano U; Akhtar J; Shaikh Y; Yar MS
Polim Med; 2023; 53(1):81-89. PubMed ID: 37260126
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab.
Jiang S; Geng S; Gao X; Liu T; Luo X; Wang N; Shi N; Dong M
Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):616-625. PubMed ID: 36809922
[No Abstract] [Full Text] [Related]
13. Validation of a supplementary condition of eighth AJCC staging system for stage II hepatocellular carcinoma.
Li M; Wu L; Luo S; Liu Y; Sun C; Li E; Wang J; Li B; Huang Z; Ge J; Lei J; Zhou F; Liao W
Eur J Surg Oncol; 2023 Jul; 49(7):1217-1225. PubMed ID: 36690533
[TBL] [Abstract] [Full Text] [Related]
14. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for treatment of Hepatocellular Carcinoma.
Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
[TBL] [Abstract] [Full Text] [Related]
15. Radiomic analysis based on multi-phase magnetic resonance imaging to predict preoperatively microvascular invasion in hepatocellular carcinoma.
Li YM; Zhu YM; Gao LM; Han ZW; Chen XJ; Yan C; Ye RP; Cao DR
World J Gastroenterol; 2022 Jun; 28(24):2733-2747. PubMed ID: 35979164
[TBL] [Abstract] [Full Text] [Related]
16. Construction and Validation of Prediction Model of Severe Abdominal Pain Post-Transarterial Chemoembolization in Patients with HBV-Associated Primary liver cancer.
Yang Y; Chen S; Yan Z; Jiao Y; Yan X; Li Y
Comput Math Methods Med; 2022; 2022():5203166. PubMed ID: 35941895
[TBL] [Abstract] [Full Text] [Related]
17. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database.
Zhang H; Du X; Dong H; Xu W; Zhou P; Liu S; Qing X; Zhang Y; Yang M; Zhang Y
BMC Gastroenterol; 2022 Jul; 22(1):348. PubMed ID: 35854221
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic performance of [
Mirshahvalad SA; Hinzpeter R; Kohan A; Anconina R; Kulanthaivelu R; Ortega C; Metser U; Veit-Haibach P
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4205-4217. PubMed ID: 35705874
[TBL] [Abstract] [Full Text] [Related]
19. Technique of vessel-skeletonized parenchyma-sparing hepatectomy for the oncological treatment of bilobar colorectal liver metastases.
Umeda Y; Nagasaka T; Takagi K; Yoshida R; Yoshida K; Fuji T; Matsuda T; Yasui K; Kumano K; Sato H; Yagi T; Fujiwara T
Langenbecks Arch Surg; 2022 Mar; 407(2):685-697. PubMed ID: 34839388
[TBL] [Abstract] [Full Text] [Related]
20. GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma
Brun S; Bestion E; Raymond E; Bassissi F; Jilkova ZM; Mezouar S; Rachid M; Novello M; Tracz J; Hamaï A; Lalmanach G; Vanderlynden L; Legouffe R; Stauber J; Schubert T; Plach MG; Courcambeck J; Drouot C; Jacquemot G; Serdjebi C; Roth G; Baudoin JP; Ansaldi C; Decaens T; Halfon P
Autophagy; 2022 Mar; 18(3):678-694. PubMed ID: 34740311
[TBL] [Abstract] [Full Text] [Related]
[Next]
